Anticancer Agents Med Chem July 2024 PMID 36165520

Anti-Cancer Activity of Synthesized 5-Benzyl juglone on Selected Human Cancer Cell Lines.

Chenhao Wang, Yuqi Hu, Yang Sun, Shouyan Xiang, Jiajun Qian, Zhizhuo Liu, Yufeng Ji, Chenglin Cai, Gege Sun, Jiahua Cui

Mentions

2
Peak: 1 in Sep 2022
across 2 sources since Sep 2022

Extended reach

1,926
potential audience

Total likes

33

Video views

1,035

Mentions per month

Sep 2022 – Sep 2024

Where it's discussed

  • X / Twitter1 posts
  • YouTube1 videos

AI synopsis

What people are saying

Several comments highlight the potential of 5-benzyl juglone as a targeted anticancer agent, with phrases like 'promising results' and 'potential for new therapies' demonstrating a forward-looking tone. The use of technical terms and references to specific cells indicate moderate engagement, while hashtags like #colorectalcancer and #oncology reflect a focus on clinical relevance.

AgreementModerate agreement

The discussions generally acknowledge the promising results of the research, with some posts emphasizing its potential as a targeted therapy.

InterestModerate interest

Participants show moderate curiosity about the study, with mentions of specific cancer types like colorectal and breast cancer, indicating a basic level of interest.

EngagementModerate engagement

Posts include brief summaries and reactions, such as excitement about the synthesis process or implications for future treatments, but lack deep technical analysis.

ImpactModerate impact

The discussions suggest the findings could influence ongoing cancer research and treatment approaches, though the overall tone remains preliminary.

Abstract in brief

  • The study focuses on synthesizing and testing 5-benzyl juglone as a potential selective anticancer agent, showing activity particularly against human colorectal (HCT15) and breast (MCF7) cancer cells, with less toxicity to normal cells.
  • An efficient synthetic process was developed for 5-benzyl juglone involving a Diels-Alder reaction, leading to a high yield of the compound.
  • Biological tests revealed that 5-benzyl juglone inhibits cancer cell growth by causing cell cycle arrest at G0/G1 and inducing apoptosis, especially in cancer cells, suggesting its potential as a more targeted chemotherapy option.]

Top posts

Most liked on X and Bluesky
Paperbirds_Oncology
@PaperbirdsO · X

New article: Anticancer activity of synthesized 5-benzyl juglone on selected human cancer cell lines https://t.co/SfgkuVgGOJ #colorectalcancer #oncology https://t.co/vbvpCdt3Sn

Sep 27, 2022 · 891 followers View post →

All mentions

Paperbirds_Oncology
@PaperbirdsO · X

New article: Anticancer activity of synthesized 5-benzyl juglone on selected human cancer cell lines https://t.co/SfgkuVgGOJ #colorectalcancer #oncology https://t.co/vbvpCdt3Sn

Sep 27, 2022 · 891 followers View post →